Session

Breaking the ‘therapeutic ceiling’ in the management of Crohn’s disease: hype or hope? (Takeda Pharmaceuticals International AG)

Breaking the ‘therapeutic ceiling’ in the management of Crohn’s disease: hype or hope? (Takeda Pharmaceuticals International AG)
Breaking the ‘therapeutic ceiling’ in the management of Crohn’s disease: hype or hope? (Takeda Pharmaceuticals International AG)

Breaking the ‘therapeutic ceiling’ in the management of Crohn’s disease: hype or hope? (Takeda Pharmaceuticals International AG)  et al.

Item 1 - 1 / 1
1